Results 11 to 20 of about 229,737 (177)

C-233 INAUGURÓ IPN EL IX CONGRESO NACIONAL ESTUDIANTIL DE INVESTIGACIÓN 2014

open access: yes, 2014
C-233 INAUGURÓ IPN EL IX CONGRESO NACIONAL ESTUDIANTIL DE INVESTIGACIÓN 2014C-233 INAUGURÓ IPN EL IX CONGRESO NACIONAL ESTUDIANTIL DE INVESTIGACIÓN ...
Comunicación Social, Comunicados
core   +15 more sources

University of Essex at the TAC 2011 Multilingual Summarisation Pilot [PDF]

open access: yes, 2011
We present the results of our Arabic and English runs at the TAC 2011 Multilingual summarisation (MultiLing) task. We participated with centroid-based clustering for multidocument summarisation.
Kruschwitz, Udo   +2 more
core   +3 more sources

TAC-1 Antibody Validation.

open access: yes, 2022
(A) Verification of TAC-1 antibody using IF imaging of one-cell mitotic embryos. TAC-1 localizes to centrosomes, and colocalizes with ZYG-9, as previously described [14,33].
Justin D. Finkle (10870793)   +6 more
core   +1 more source

TAC-1 and ZYG-9 are interdependent for localization to acentrosomal poles.

open access: yes, 2022
(A) IF imaging of oocyte spindles; shown are DNA (blue), TAC-1 (green), ZYG-9 (stained with a GFP antibody; red), and tubulin (not shown in merge). Colocalization of TAC-1 and ZYG-9 is evident in metaphase and persists throughout anaphase (12/12 spindles)
Justin D. Finkle (10870793)   +6 more
core   +1 more source

Pharmacological chromatin remodeling enhances response to estrogen therapy in ER+ breast cancer

open access: yesMolecular Oncology, EarlyView.
Estrogen therapy elicits clinical benefit in ~ 30% of patients with endocrine‐resistant estrogen receptor (ER)‐positive breast cancer. Based on findings that ER transcriptional activation underlies response to estrogen therapy, we tested the effects of epigenetic dysregulation via pharmacological inhibition of histone deacetylases (HDACi).
Anneka L. Johnson Thomas   +16 more
wiley   +1 more source

Loss of AMBRA1 activates MAPK and angiogenesis signaling pathways in melanoma cells

open access: yesFEBS Open Bio, EarlyView.
Loss of AMBRA1 in melanoma cells activates multiple oncogenic pathways associated with tumor progression. Transcriptomic and protein network analyses revealed that AMBRA1 depletion enhances MAPK/ERK signaling, angiogenesis, TGF‐β/EMT signaling, and Wnt/axon guidance pathways.
Milad Ibrahim   +4 more
wiley   +1 more source

TAC-induced cardiac remodeling.

open access: yes, 2017
A,Left, Representative 2D images and Doppler traces across the aortic arch in sham-operated and TAC mice at 8 w after surgery demonstrating marked elevated blood flow velocity in TAC mice.
Sumanth D. Prabhu (549964)   +4 more
core   +1 more source

Comparative Effectiveness and Safety of Inebilizumab Versus Rituximab in AQP4‐IgG‐Positive NMOSD

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Rituximab (anti‐CD20, RTX) and inebilizumab (anti‐CD19, INE) represent B‐cell‐depleting therapies used for aquaporin‐4 antibody‐positive (AQP4‐IgG+) neuromyelitis optica spectrum disorder (NMOSD); however, direct comparative evidence remains limited.
Jie Lin   +11 more
wiley   +1 more source

Tac-S Tajima's D

open access: yes, 2015
Tajima's D output for 1000bp windows for Tac-S. There is no option in the script to suppress the non-informative windows, so there are lots of windows with "na" that fail the coverage criteria so no calculation is ...
Barbara Feldmeyer (3242292)   +5 more
core   +1 more source

Bioinspired Adaptive Surfaces for Intelligent Liquid Manipulation: Progressing From Passive and Active to Hybrid Strategies

open access: yesAdvanced Materials, EarlyView.
This review examines passive, active, and hybrid liquid manipulation strategies, highlighting hybrid approaches as an emerging route to reconcile energy efficiency with adaptive control. By actively reconstructing passive surfaces to store programmable interfacial energy, hybrid systems enable flexible yet low‐power liquid transport, with perspectives ...
Jiaqi Miao   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy